Teva Pharmaceutical Industries announced that Eric Hughes, EVP of Global R&D & Chief Medical Officer, will present at the BofA Securities Health Care Conference on May 12, 2026. The presentation will cover Teva's innovative biopharmaceutical developments and strategic plans, reflecting its commitment to advancing health through neuroscience, immunology, generics, and biosimilars. This event offers investors insight into Teva's growth strategy and pipeline progress. The presentation will be webcast live and archived for 30 days on Teva's investor relations website.
Polaris Inc. reported a strong quarterly performance with earnings per share of $1.97, beating estimates by over 155%, and revenues of $2.02 billion, up 9.2% year-over-year. The growth was driven by sales recovery in the utility off-road vehicle segm...
Seagate Technology is set to report its Q2 2026 earnings with analysts expecting an EPS of $5.10 and revenue around $3.5 billion, reflecting strong demand for data storage driven by AI growth. The company's optimistic guidance aligns with these estim...
Teladoc Health, a leader in virtual healthcare services, has seen its average analyst price target rise from $8.35 to $11.00, reflecting increased confidence in its market position. The stock recently jumped 6.1% with high trading volume, driven by r...
Procter & Gamble, a leading consumer goods company and Dividend King, is seeing a decline in analyst price targets from $162.52 to $152 over the past year, though Deutsche Bank remains optimistic with a $177 target. Despite a strong history of beatin...
Cognizant Technology Solutions has seen a decline in analyst price targets from $74.94 to $56.33 over the past year, reflecting increased caution about its stock performance. Despite this, some analysts remain optimistic, with a notable price target ...
